Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Virally targeted therapies for EBV-associated malignancies

Oncogene volume 22, pages 5122–5130 (2003)Cite this article

Abstract

In Epstein–Barr virus (EBV)-positive lymphomas, the presence of the EBV genome in virtually all tumor cells, but very few normal cells, suggests that novel, EBV-targeted therapies could be used to treat these malignancies. In this paper, we review a variety of different approaches currently under development that specifically target EBV-infected cells for destruction. EBV-based strategies for treating cancer include prevention of viral oncogene expression, inducing loss of the EBV episome, the purposeful induction of the lytic form of EBV infection, and enhancing the host immune response to virally encoded antigens.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Aghi M, Kramm CM, Chou TC, Breakefield XO and Chiocca EA . (1998). J. Natl. Cancer Inst. (Bethesda), 90, 370–380.

  • Adamson AL, Darr D, Holley-Guthrie E, Johnson RA, Mauser A, Swenson J and Kenney SC . (2000). J. Virol., 74, 1224–1233.

  • Ambinder R, Robertson K, Moore S and Yang J . (1996). Semin. Cancer Biol., 7, 217–227.

  • Ben-Sasson SA and Klein G . (1981). Int. J. Cancer, 28, 131–135.

  • Binne U, Amon W and Farrell P . (2002). J. Virol., 76, 10282–10289.

  • Bollard CM, Rossig C, Calonge MJ, Huls MH, Wagner HJ, Massague J, Brenner MK, Heslop HE and Rooney CM . (2002). Blood., 99, 3179–3187.

  • Bonnet M, Guinebretiere JM, Kremmer E, Grunewald V, Benhamou E, Contesso G and Joab I . (1999). J. Natl. Cancer Inst., 91, 1376–1381.

  • Bryant H and Farrell P . (2002). J. Virol., 76, 10290–10298.

  • Cahir-McFarland ED, Davidson DM, Schauer SL, Duong J and Kieff E . (2000). Proc. Natl. Acad. Sci. USA, 97, 6055–6060.

  • Campbell KS . (1999). Curr. Opin. Immunol., 11, 256–264.

  • Cayrol C and Flemington EK . (1996). EMBO J., 15, 2748–2759.

  • Chang Y, Dong D, Hayward G and Hayward SD . (1990). J. Virol., 64, 3358–3369.

  • Chang LK and Liu ST . (2000). Nucleic Acids Res., 28, 3918–3925.

  • Chapman AL, Rickinson AB, Thomas WA, Jarrett RF, Crocker J and Lee SP . (2001). Cancer Res., 61, 6219–6226.

  • Chatila T, Ho N, Liu P, Liu S, Mosialos G, Kieff E and Speck SH . (1997). J. Virol., 71, 6560–6567.

  • Chen C, Chang Y, Ryan P, Linscott M, McGarrity G and Chiang Y . (1995). Hum. Gene Ther., 6, 1467–1476.

  • Chevallier-Greco A, Manet E, Chavrier P, Mosnier C, Dallie J and Sergeant A . (1986). EMBO J., 5, 3243–3249.

  • Chodosh J, Holder VP, Gan YJ, Belgaumi A, Sample J and Sixbey JW . (1998). J. Infect. Dis., 177, 1194–1201.

  • Chua D, Huang J, Zheng B, Lau SY, Luk W, Kwong DL, Sham JS, Moss D, Yuen KY, Im SW and Ng MH . (2001). Int. J. Cancer., 94, 73–80.

  • Coburn GA and Cullen BR . (2002). J. Virol., 76(18), 9225–9231.

  • Conners TA . (1995). Gene Ther., 2, 702–709.

  • Countryman J and Miller G . (1985). Proc. Natl. Acad. Sci. USA., 82, 4085–4089.

  • Daibata M, Speck SH, Mulder C and Sairenji T . (1994). Virology, 198, 446–454.

  • Darr CD, Mauser A and Kenney S . (2001). J. Virol., 75, 6135–6142.

  • Datta R, Taneja N, Sukhatme VP, Qureshi SA, Weichselbaum R and Kufe DW . (1993). Proc. Natl. Acad. Sci. USA., 15, 2419–2422.

  • Davies AH, Grand RJ, Evans FJ and Rickinson AB . (1991). J. Virol., 65, 6838–6844.

  • Dhar SK, Yoshida K, Machida Y, Khaira P, Chaudhuri B, Wohlschlegel JA, Leffak M, Yates J and Dutta A . (2001). Cell., 106, 287–296.

  • Faggioni A, Zompetta C, Grimaldi S, Barile G, Frati L and Lazdins J . (1986). Science, 232, 1554–1556.

  • Falk KI and Ernberg I . (1999). Arch. Virol., 144, 2219–2227.

  • Farrell P, Rowe D, Rooney C and Kouozarides T . (1989). EMBO J., 8, 127–132.

  • Feederle R, Kost M, Baumann M, Janz A, Drouet E, Hammerschmidt W and Delecluse HJ . (2000). EMBO J., 19, 3080–3089.

  • Feng WH, Israel BF, Raab-Traub N, Busson P and Kenney SC . (2002a). Cancer Res., 62, 1920–1926.

  • Feng WH, Westphal E, Mauser A, Raab-Traub N, Gulley ML, Busson P and Kenney SC . (2002b). J. Virol., 76, 10951–10959.

  • Flemington E and Speck S . (1990). J. Virol., 64, 1227–1232.

  • Franken M, Estabrooks A, Cavacini L, Sherburne B, Wang F and Scadden DT . (1996). Nat. Med., 2, 1379–1382.

  • Freeman SM, Abboud CN, Whartenby KA, Packman CH, Koeplin DS, Moolten DFL and Abraham GN . (1993). Cancer Res., 53, 5274–5283.

  • Gahn B, Siller-Lopez F, Pirooz AD, Yvon E, Gottschalk S, Longnecker R, Brenner MK, Heslop HE, Aguilar-Cordova E and Rooney CM . (2001). Int. J. Cancer., 93, 706–713.

  • Gitlin L, Karelsky S and Andino R . (2002). Nature., 418, 430–434.

  • Gottschalk S, Ng CY, Perez M, Smith CA, Sample C, Brenner MK, Heslop HE and Rooney CM . (2001). Blood., 97, 835–843.

  • Gradoville L, Kwa D, El-Guindy A and Miller G . (2002). J. Virol., 76, 5612–5626.

  • Grinstein S, Preciado MV, Gattuso P, Chabay PA, Warren WH, De Matteo E and Gould VE . (2002). Cancer Res., 62, 4876–4878.

  • Gruffat H, Manet E and Sergeant A . (2002). EMBO Rep., 3, 141–146.

  • Guitierrez MI, Judde JG, Magrath I and Bhatia KG . (1996). Cancer Res., 56, 969–972.

  • Hardwick JM, Lazarowits S and Hayward SD . (1998). J. Virol., 62, 2274–2284.

  • Hirai H, Satoh E, Osawa M, Inaba T, Shimazaki C, Kinoshita S, Nakagawa M, Mazda O and Imanishi J . (1997). Biochem. Biophys. Res. Commun., 241, 112–118.

  • Inman GJ, Binne UK, Parker GA, Farrell PJ and Allday MJ . (2001). J. Virol., 75, 2400–2410.

  • Jenkins P, Binne U and Farrell P . (2000). J. Virol., 74, 710–720.

  • Jiang M and Milner J . (2002). Oncogene., 21, 6041–6048.

  • Judde JG, Spangler G, Magrath I and Bhatia K . (1996). Hum. Gene Ther., 7, 647–653.

  • Kenney JL, Guinness ME, Curiel T and Lacy J . (1998a). Blood., 92, 1721–1727.

  • Kenney S, Ge JQ, Westphal EM and Olsen J . (1998b). Hum. Gene Ther., 9, 1131–1141.

  • Kieff E . (2001). Field's Virology. Vol. 2. Lippincott: Philadelphia, PA, pp 2343–2396.

    Google Scholar 

  • Kieff E and Rickinson A . (2001). Field's Virology. Vol. 2. Lippincott: Philadelphia, PA, pp 2397–2446.

    Google Scholar 

  • Kim SH, Kim JH, Kolozsvary A, Brown SL and Freytag SQ . (1997). J Neuro-Oncol., 33, 189–194.

  • Kraus RJ, Mirocha SJ, Stephany HM, Puchalski JR and Mertz JE . (2001). J. Virol., 75, 867–877.

  • Lee NS, Dohjima T, Bauer G, Li H, Li MJ, Ehsani A, Salvaterra P and Rossi J . (2002). Nat. Biotechnol., 20, 500–505.

  • Li JH, Chia M, Shi W, Ngo D, Strathdee CA, Huang D, Klamut H and Liu FF . (2002). Cancer Res., 62, 171–178.

  • Lim JC, Jain N and Cao X . (1998). Oncogene, 16, 2915–2926.

  • Liu S, Liu P, Borras A, Chatila T and Speck S . (1997). EMBO J., 16, 143–153.

  • Luka J, Kallin B and Klein G . (1979). Virology, 94, 228–11-18.

  • Meij P, Leen A, Rickinson AB, Verkoeijen S, Vervoort MB, Bloemena E and Middeldorp JM . (2002). Int. J. Cancer., 99, 93–99.

  • Mentzer SJ, Fingeroth J, Reilly JJ, Perrine SP and Faller DV . (1998). Blood Cells Mol. Dis., 24, 114–123.

  • Mentzer SJ, Perrine SP and Faller D . (2001). Transplant. Infect. Dis., 3, 177–185.

  • Miller CL, Burkhardt AL, Lee JH, Stealey B, Longnecker R, Bolen JB and Kieff E . (1995). Immunity, 2, 155–166.

  • Montalvo EA, Cottam M, Hill S and Wang YJ . (1995). J. Virol., 69, 4158–4165.

  • Moore SM, Cannon JS, Tanhehco YC, Hamzeh FM and Ambinder RF . (2001). Antimicrob. Agents Chemother., 45, 2082–2091.

  • Murray RJ, Kurilla MG, Brooks JM, Thomas WA, Rowe M, Kieff E and Rickinson AB . (1992). J. Exp. Med., 176, 157–168.

  • Murono S, Yoshizaki T, Sato H, Takeshita H, Furukawa M and Pagano JS . (2000). Cancer Res., 60, 2555–2561.

  • Novina CD, Murray MF, Dykxhoorn DM, Beresford PJ, Riess J, Lee SK, Collman RG, Lieberman J, Shankar P and Sharp PA . (2002). Nat. Med., 8, 681–686.

  • Putnam DA . (1996). Am. J. Health Syst. Pharmcol., 53, 151–160.

  • Ragoczy T, Heston L and Miller G . (1998). J. Virol., 72, 7978–7984.

  • Reisman D, Yates J and Sugden B . (1985). Mol. Cell. Biol., 5, 1822–1832.

  • Robertson KD, Barletta J, Samid D and Ambinder RF . (1995). Curr. Top. Microbiol. Immunol., 194, 145–154.

  • Rooney C, Rowe D, Ragot T and Farrell P . (1989). J. Virol., 63, 3109–3116.

  • Rooney C, Taylor N, Countryman J, Jenson H, Kolman J and Miller G . (1988). Proc. Natl. Acad. Sci. USA, 85, 9801–9805.

  • Rooney CM, Roskrow MA, Smith CA, Brenner MK and Heslop HE . (1998). J. Natl. Cancer Inst. Monogr., 23, 89–93.

  • Roskrow MA, Suzuki N, Gan Y, Sixbey JW, Ng CY, Kimbrough S, Hudson M, Brenner MK, Heslop HE and Rooney CM . (1998). Blood., 91, 2925–2934.

  • Ruf IK, Rhyne PW, Yang H, Borza CM, Hutt-Fletcher LM, Cleveland JL and Sample JT . (1999). Mol. Cell. Biol., 19, 1651–1660.

  • Slobod KS, Taylor GH, Sandlund JT, Furth P, Helton KJ and Sixbey JW . (2000). Lancet., 356, 1493–1494.

  • Speck S, Chatila T and Flemington E . (1997). Trends Microbiol., 5, 399–405.

  • Su Z, Peluso MV, Raffegerst SH, Schendel DJ and Roskrow MA . (2001). Eur. J. Immun., 31, 947–958.

  • Sugawara Y, Makuuchi M and Takada K . (2000). Scand. J. Gastroenterol., 35, 981–984.

  • Takada K . (1984). Int. J. Cancer, 33, 27–32.

  • Takada K, Shimizu N, Sakuma S and Ono Y . (1986). J. Virol., 57, 1016–1022.

  • Tamir Y and Bengal E . (2000). J. Biol. Chem., 275, 34424–34432.

  • Tiberghien P . (1994). J. Leukamia Biol., 56, 203–209.

  • vanDam H, Wilhelm D, Herr I, Steffen A, Herrlich P and Angel P . (1995). EMBO J, 14, 1798–1811.

  • Wang J-M, Chao J-R, Chen W, Kuo M-L, Yen J-Y and Yang-Yen H-F . (1999). Mol. Cell. Biol., 19, 6195–6206.

  • Wang Y, Huang J and Montalvo E . (1997). Virology, 227, 323–330.

  • Westphal EM, Blackstock W, Feng WH, Israel BF and Kenney SC . (2000a). Cancer Res., 60, 5781–5788.

  • Westphal E, Ge J, Catchpole J, Ford M and Kenney S . (2000b). Cancer Gene Ther., 7, 97–106.

  • Westphal EM, Mauser A, Swenson J, Davis MG, Talarico CL and Kenney S . (1999). Cancer Res., 59, 1485–1491.

  • Wildner O, Blaese RM and Candotti F . (1999). Cancer Res., 59, 5233–5238.

  • Zalani S, Coppage A, Holley-Guthrie E and Kenney S . (1997). J. Virol., 71, 3268–3274.

  • Zalani S, Holley-Guthrie E, Gutsch D and Kenney S . (1992). J. Virol., 66, 7282–7292.

  • Zalani S, Holley-Guthrie E and Kenney S . (1995). J. Virol., 69, 3816–3823.

  • Zalani S, Holley-Guthrie E and Kenney S . (1996). Proc. Natl. Acad. Sci. USA, 93, 9194–9199.

  • Zhao M, New L, Kravchenko VV, Kato Y, Gram H, di Padova F, Olson EN, Ulevitch RJ and Han J . (1999). Mol. Cell. Biol., 19, 21–30.

  • Zur Hausen H, O'Neil F and Freese U . (1978). Nature, 272, 373–375.

Download references

Acknowledgements

This work was supported by NIH Grants R01-CA66519, RO1-CA58853, and K23-AI51200.

Author information

Authors and Affiliations

  1. Department of Medicine, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, CB# 7295, Chapel Hill, 27599-7295, NC, USA

    Bruce F Israel & Shannon C Kenney

  2. Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, CB# 7295, Chapel Hill, 27599-7295, NC, USA

    Shannon C Kenney

Authors
  1. Bruce F Israel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shannon C Kenney
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shannon C Kenney.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Israel, B., Kenney, S. Virally targeted therapies for EBV-associated malignancies. Oncogene 22, 5122–5130 (2003). https://doi.org/10.1038/sj.onc.1206548

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206548

Keywords

This article is cited by

Search

Advanced search

Quick links